| RVA Removal from Official List - Annual Listing Fees |
| 29/08/19 | | 79.57KB | Share |
|
| RVA Suspension from Official Quotation - Annual Listing Fee |
| 22/08/19 | PRICE SENSITIVE | 440.19KB | Share |
|
| RVA REVA Receives Additional Interim Funding |
| 05/08/19 | PRICE SENSITIVE | 97.3KB | Share |
|
| RVA REVA Receives Interim Funding and Amends License Agreement |
| 08/04/19 | PRICE SENSITIVE | 1.32MB | Share |
|
| RVA Receipt of Interim Funding Commitment and Leadership Changes |
| 25/03/19 | PRICE SENSITIVE | 52.54KB | Share |
|
| RVA REVA Continues Suspension of Trading |
| 13/03/19 | | 90.38KB | Share |
|
| RVA S&P DJI Announces March 2019 Quarterly Rebalance |
| 08/03/19 | PRICE SENSITIVE | 175.31KB | Share |
|
| RVA Extension of Voluntary Suspension |
| 06/03/19 | | 119.71KB | Share |
|
| RVA Extension to Voluntary Suspension |
| 25/02/19 | | 120KB | Share |
|
| RVA Response to ASX Appendix 4C Query Letter |
| 22/02/19 | PRICE SENSITIVE | 476.5KB | Share |
|
| RVA Voluntary Suspension |
| 20/02/19 | PRICE SENSITIVE | 353.98KB | Share |
|
| RVA Trading Halt |
| 18/02/19 | PRICE SENSITIVE | 334.91KB | Share |
|
| RVA REVA Announces Reduction in Force |
| 05/02/19 | PRICE SENSITIVE | 38.57KB | Share |
|
| RVA Appendix 4C - quarterly |
| 31/01/19 | PRICE SENSITIVE | 136.93KB | Share |
|
| RVA REVA expands Geographic Footprint to Seven New Countries |
| 07/01/19 | PRICE SENSITIVE | 52.69KB | Share |
|
| RVA CFO and Company Secretary Appointment/Resignation |
| 04/01/19 | | 46.03KB | Share |
|
| RVA First Fantom Encore Bioresorbable Scaffold Implant in Italy |
| 04/12/18 | | 53.57KB | Share |
|
| RVA Appendix 3B |
| 28/11/18 | | 192.87KB | Share |
|
| RVA REVA Medical to Present at Canaccord Genuity Forum |
| 15/11/18 | PRICE SENSITIVE | 1.97MB | Share |
|
| RVA REVA Announces Departure of Richard Kimes, SVP of Operations |
| 08/11/18 | | 49.18KB | Share |
|
| RVA Q3 2018 Quarterly Report on Form 10-Q |
| 06/11/18 | PRICE SENSITIVE | 422.39KB | Share |
|
| RVA REVA Medical Reports Third Quarter 2018 Financial Results |
| 06/11/18 | PRICE SENSITIVE | 122.16KB | Share |
|
| RVA Commercial Launch of Fantom Encore Bioresorbable Scaffold |
| 01/11/18 | PRICE SENSITIVE | 53.77KB | Share |
|
| RVA REVA to Hold Third Quarter 2018 Financial Results Call |
| 30/10/18 | | 44.17KB | Share |
|
| RVA Appendix 4C - quarterly |
| 30/10/18 | PRICE SENSITIVE | 106.34KB | Share |
|
| RVA Appendix 3B |
| 08/10/18 | | 256.02KB | Share |
|
| RVA Appendix 3B |
| 25/09/18 | | 204.6KB | Share |
|
| RVA Reva Medical Presents Key Data Sets at TCT 2018 |
| 24/09/18 | | 2.46MB | Share |
|
| RVA New Data to be Presented at the TCT 2018 Conference |
| 16/08/18 | PRICE SENSITIVE | 54.18KB | Share |
|
| RVA Half Yearly Report and Accounts (Appendix 4D) |
| 08/08/18 | PRICE SENSITIVE | 1.05MB | Share |
|
| RVA REVA Medical Reports Second Quarter 2018 Financial Results |
| 07/08/18 | PRICE SENSITIVE | 474.5KB | Share |
|
| RVA REVA Enters into Amendment to License Agreement with Rutgers |
| 06/08/18 | PRICE SENSITIVE | 154.22KB | Share |
|
| RVA REVA to Hold Second Quarter 2018 Financial Results Call |
| 01/08/18 | | 44.59KB | Share |
|
| RVA Appendix 4C - quarterly |
| 30/07/18 | PRICE SENSITIVE | 210.92KB | Share |
|
| RVA REVA Enters Peripheral Artery Disease Space with MOTIV |
| 26/07/18 | PRICE SENSITIVE | 53.21KB | Share |
|
| RVA REVA Expands Commercial Access to Fantom in Italy |
| 16/07/18 | PRICE SENSITIVE | 53.95KB | Share |
|
| RVA Appendix 3B |
| 06/07/18 | | 206.63KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 80.78KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 75.2KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 75.34KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 84.03KB | Share |
|
| RVA Change of Director's Interest Notice |
| 03/07/18 | | 78.55KB | Share |
|
| RVA Institutional Investor Briefing |
| 27/06/18 | | 2.12MB | Share |
|
| RVA CE Mark Approval of the Full Fantom Encore Product Line |
| 19/06/18 | PRICE SENSITIVE | 53.05KB | Share |
|
| RVA Change of Director's Interest Notice |
| 18/06/18 | | 81.12KB | Share |
|
| RVA Change of Director's Interest Notice |
| 04/06/18 | | 81.14KB | Share |
|
| RVA REVA Announces Positive 24-Month Clinical Results |
| 24/05/18 | PRICE SENSITIVE | 60.9KB | Share |
|
| RVA REVA Symposium Showcases Clinical Data |
| 24/05/18 | PRICE SENSITIVE | 5.43MB | Share |
|
| RVA Appendix 3B |
| 21/05/18 | | 176.55KB | Share |
|
| RVA Final Director's Interest Notice |
| 21/05/18 | | 64.64KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 81.44KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 84.92KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 75.02KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 75.18KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 76.59KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 79.39KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 83.64KB | Share |
|
| RVA Change of Director's Interest Notice |
| 21/05/18 | | 78.23KB | Share |
|
| RVA Results of Annual General Meeting |
| 17/05/18 | | 76.78KB | Share |
|
| RVA Annual General Meeting Presentation |
| 17/05/18 | | 1.98MB | Share |
|
| RVA REVA Announces First Implant of Fantom in Turkey |
| 16/05/18 | PRICE SENSITIVE | 54.32KB | Share |
|
| RVA REVA to Hold Annual General Meeting of Stockholders |
| 10/05/18 | | 43.07KB | Share |
|
| RVA Q1 2018 Quarterly Report on Form 10-Q |
| 10/05/18 | | 205.37KB | Share |
|
| RVA REVA Medical Reports First Quarter 2018 Financial Results |
| 09/05/18 | PRICE SENSITIVE | 82.84KB | Share |
|
| RVA REVA to Hold First Quarter 2018 Financial Results Call |
| 02/05/18 | | 43.03KB | Share |
|
| RVA Appendix 4C - quarterly |
| 30/04/18 | PRICE SENSITIVE | 105.62KB | Share |
|
| RVA REVA to Present Full Two-Year Fantom II Data at EuroPCR |
| 17/04/18 | | 50.36KB | Share |
|
| RVA Notice of Meeting and Proxy Statement for 2018 AGM |
| 06/04/18 | | 2.45MB | Share |
|
| RVA REVA Initiates Commercial Distribution Partnership in Turkey |
| 03/04/18 | PRICE SENSITIVE | 51.03KB | Share |
|
| RVA Change of Directors Interest Notice |
| 03/04/18 | | 81.14KB | Share |
|
| RVA Change of Director's Interest Notice |
| 29/03/18 | | 81.08KB | Share |
|
| RVA Appendix 4G |
| 29/03/18 | | 130.52KB | Share |
|
| RVA REVA Announces First Implant of Fantom Encore in Switzerland |
| 28/03/18 | PRICE SENSITIVE | 50.54KB | Share |
|
| RVA Board Member Not Standing for Re-Election |
| 27/03/18 | | 48.63KB | Share |
|
| RVA Institutional Investor Briefing |
| 14/03/18 | | 1.88MB | Share |
|
| RVA Appendix 3B |
| 09/03/18 | | 195.56KB | Share |
|
| RVA Change of Director's Interest Notice |
| 09/03/18 | | 85.58KB | Share |
|
| RVA Form S-8 Filed with the SEC |
| 08/03/18 | | 82.21KB | Share |
|
| RVA Annual Report on Form 10-K |
| 08/03/18 | | 860.13KB | Share |
|
| RVA REVA Reports 2017 Financial Results |
| 08/03/18 | PRICE SENSITIVE | 83.07KB | Share |
|
| RVA REVA to Present at Cowen 38th Annual Health Care Conference |
| 07/03/18 | | 41.95KB | Share |
|
| RVA REVA to hold Financial Results Call |
| 01/03/18 | | 43.24KB | Share |
|
| RVA Preliminary Final Report |
| 28/02/18 | PRICE SENSITIVE | 410.08KB | Share |
|
| RVA REVA Announces CE Mark and First Implant of Fantom Encore |
| 26/02/18 | PRICE SENSITIVE | 54.47KB | Share |
|
| RVA Initial Director's Interest Notice |
| 06/02/18 | | 62.36KB | Share |
|
| RVA Director Appointment |
| 05/02/18 | | 52.99KB | Share |
|
| RVA Appendix 4C - Quarterly |
| 01/02/18 | PRICE SENSITIVE | 101.73KB | Share |
|
| RVA First Implant of the Fantom Bioresorbable Scaffold in Italy |
| 25/01/18 | PRICE SENSITIVE | 50.42KB | Share |
|
| RVA Notification of Distribution of Substantial Holder Shares |
| 11/01/18 | | 269.81KB | Share |
|
| RVA Institutional Investor Briefing |
| 08/01/18 | | 1.96MB | Share |
|
| RVA REVA to present at Piper Jaffray Healthcare Conference |
| 28/11/17 | | 1.3MB | Share |
|
| RVA Appendix 3B |
| 10/11/17 | | 183.74KB | Share |
|
| RVA REVA Medical reports Third Quarter 2017 Financial Results |
| 08/11/17 | PRICE SENSITIVE | 107.77KB | Share |
|
| RVA REVA to Present at Canaccord Genuity Forum |
| 02/11/17 | | 43.74KB | Share |
|
| RVA REVA to Hold Third Quarter 2017 Financial Results Call |
| 01/11/17 | | 44.52KB | Share |
|
| RVA New Fantom Data Demonstrates Safety at 2 Years |
| 01/11/17 | PRICE SENSITIVE | 2.87MB | Share |
|
| RVA Appendix 4C - quarterly |
| 31/10/17 | PRICE SENSITIVE | 136.98KB | Share |
|
| RVA REVA to Present Fantom 24-Month Data at TCT 2017 |
| 24/10/17 | | 47.31KB | Share |
|
| RVA Launch of Fantom in Switzerland |
| 16/10/17 | PRICE SENSITIVE | 47.12KB | Share |
|
| RVA Institutional Investor Briefing |
| 11/10/17 | | 1.45MB | Share |
|
